Literature DB >> 835553

Acid and gastrin levels after bombesin and calcium infusion in patients with incomplete antrectomy.

N Basso, E Lezoche, S Giri, M Percoco, V Speranza.   

Abstract

In 17 patients with postoperative recurrent peptic ulcer, incomplete antrectomy (I.A.) was found by endoscopic biopsies in 5. No evidcence of I.A. was found in the remaining 12 patients. Gastric acid output and gastrin levels were measured in basal conditions and following a calcium I.V. infusion (4 mg/kg hr of Ca++ over 4 hr) and a bombesin (BBS) I.V. infusion (15 ng/kg min over 90 min). Basal gastrin levels were significantly differnt in the two groups of patients: BBS infusion augmented significantly serum gastrin levels in all patients with I.S., while BBS infusion had no significant effect on serum gastrin levels in the group of patients without I.A. Acid output following BBS infusion showed a pattern similar to the pattern seen for gastrin. Calcium infusion augmented gastric acid secretion and gastrin levels in the patients with I.A.; however, the response to calcium could not clearly separate in all instances patients with I.A. from patients without I.A. It is concluded that the "BBS infusion test" may be heplful in the diagnosis of I.A. in patients with postoperative peptic ulcer.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 835553     DOI: 10.1007/BF01072954

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  7 in total

1.  EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME.

Authors:  B A SCOBIE; D B MCGILL; J T PRIESTLEY; R A ROVELSTAD
Journal:  Gastroenterology       Date:  1964-08       Impact factor: 22.682

2.  THE DISTRIBUTION OF PYLORIC MUCOSA IN PARTIAL GASTRECTOMY SPECIMENS.

Authors:  A C DEAN; M K MASON
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

3.  The physiologic significance of retained antral tissue after partial gastrectomy.

Authors:  W R WADDELL
Journal:  Ann Surg       Date:  1956-04       Impact factor: 12.969

4.  The retained gastric antrum: clinical considerations.

Authors:  J A Van Heerden; P E Bernatz; R A Rovelstad
Journal:  Mayo Clin Proc       Date:  1971-01       Impact factor: 7.616

5.  A method of measuring the alkaline area of the stomach during operation.

Authors:  J L Stoller; T J McDonald; P J Nunn; R C Harrison
Journal:  Surg Forum       Date:  1968

6.  Ulcerogenic potential of the incompletely resected antrum.

Authors:  R C Harrison; J L Stoller
Journal:  Am J Surg       Date:  1971-08       Impact factor: 2.565

7.  Effect of bombesin on extragastric gastrin in man.

Authors:  N Basso; E Lezoche; A Materia; S Giri; V Speranza
Journal:  Am J Dig Dis       Date:  1975-10
  7 in total
  6 in total

1.  Studies with bombesin in man.

Authors:  N Basso; E Lezoche; V Speranza
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

2.  A bombesin immunoreactive peptide in milk.

Authors:  G D Jahnke; L H Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  Changes of Gastric Secretion after Bolus and Slow Intravenous Administration of Bombesin and Neurotensin.

Authors:  Konstantinos Tsalis; Orestis Ioannidis; Chrysovalantis Mariorakis; Panagiotis Christidis; Lydia Loutzidou; Ioannis Mantzoros; Efstathios Kotidis; Manousos George Pramateftakis; Nikolaos Ouzounidis; Stamatios Aggelopoulos
Journal:  Maedica (Bucur)       Date:  2021-12

4.  Gastric response to meat extract stimulation in patients with gastroduodenal ulcer and patients after vagotomy or antrectomy.

Authors:  M Tani; H Shimazu; T Takahashi; S Asakuma
Journal:  Jpn J Surg       Date:  1978-03

5.  Serum gastrin responses to bombesin and food in patients with hypergastrinemia.

Authors:  J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

6.  Brain regulation of gastric secretion: influence of neuropeptides.

Authors:  Y Taché; W Vale; J Rivier; M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.